Lower GI 2017

5 x 5 Gy

5-FU CRT

Polish Trial n=312

Trans-Tasman n=326

Inclusion (DRE) Low T3-4 Nany

Inclusion (ERUS;MRI)

T3 Nany

Primary Endpoint Local Recurrences (10% difference at 3y)

Primary Endpoint Sphincter Preservation (15% difference)